The Department of Chemistry and Biochemistry is proud of its graduates. Our alumni have achieved success as industrial chemists, research chemists, university professors, high school teachers, physicians, dentists, pharmacists, veterinarians, entrepreneurs, lawyers and many other professions. Below, read about the interesting career paths of some our alumni. Alumni, please consider contributing to this profile page by submitting your information here.
John Heck (CHM ACS 2014): Is employed as a chemist at Millipore Sigma, a subsiduary of Merck KGaA in Lenexa, KS.
Caitlin Loftus (BCH 2011): Received her combined BS/MS in Physician Assistant from D'Youville College in 2014. She is employed by Catholic Health System in the Neonatal ICU between Sister's of Charity Hospital Level III NICU & Mercy Hospital of Buffalo Level II NICU, both in Buffalo, NY.
Stephanie Krull (CHM ACS 2010): Is employed as a chemist at Niacet Corporation in Niagara Falls, NY.
Khadeeja Saleh (CHM HT 2010): Received her PharmD from the University at Buffalo in 2014 and is currently employed at Sister's of Charity Hospital in Buffalo, NY.
Elizabeth (Gruber) Brem (BCH 2006): Received her MD from the University at Buffalo in 2010. She completed her residency in Internal Medicine at Beth Israel Deaconess Medical Center (BIDMC) in Boston, a major teaching affiliate of Harvard Medical School, in 2013. She is currently a fellow in Hematology/Oncology with clinical and research interests in lymphoma.
Michael Fennie (CHM 2001): Received his Ph.D. in Organic Chemistry from The University of Pennsylvania in 2006. From 2006 - 2012 he was a Senior Research Investigator in Medicinal Chemistry at Sanofi-Aventis. Since 2012, he is an Assistant Professor of Organic Chemistry at The University of Scranton.
Thomas Kermis (CHM 1996): Received his Ph.D. in Chemical Engineering from Johns Hopkins University in 2000. While at Johns Hopkins, he was the recipient of an NSF graduate fellowship. Since 2009 he is a Technical Service & Development Manager at Dow Microbial Control and has responsibility for the Americas. He has worked in areas of polymer synthesis and application, biocide formulation, and applications including antimicrobial efficacy.
William Cline (CHM 1990): Is employed as a Chemist-Associate at Reichhold, LLC in Durham, North Carolina where he works as a synthesis chemist in the alkyd-polyester group. His specialty is waterborne alkyd latexes and their coatings.
David G. Hangauer (CHM 1974): Started his education at Canisius in 1970 as a pre-med student, but converted to a chemistry major in his sophomore year. After graduation he accepted a research position at a local polymer company for 2 years then went to graduate school at The University at Buffalo completing his Ph.D. in natural product synthesis by 1980. He then accepted a position as a medicinal chemist at Merck in Rahway, NJ where he developed expertise in drug discovery and computer-aided-drug design. As a Buffalo native he was attracted back to Buffalo in 1989 to accept a position at the University at Buffalo as Associate Professor of Medicinal Chemistry. In his academic position his laboratory developed a new technology for the discovery of protein kinase inhibitors. He also served as a consultant or Scientific Advisory Board Member for many biotechnology and pharmaceutical companies worldwide. Prof. Hangauer is the original founder of Kinex Pharmaceuticals (renamed Athenex Inc in 2015), a Buffalo biopharmaceutical company he started in 2002 as a spin out from his University laboratory research and that is largely focused on the discovery and development of novel drugs for cancer. After starting Kinex Pharmaceuticals Prof. Hangauer’s laboratory launched a new fundamental research program aimed at experimentally unraveling the detailed energetics of drugs binding to their receptors. In 2013 Prof. Hangauer retired from his academic position to serve as the Chief Scientific Officer of Kinex Pharmaceuticals. As Emeritus Professor of Medicinal Chemistry and Chemistry, as well as Kinex’s CSO, Prof. Hangauer and his former graduate students continue to publish their research on drug-receptor binding energetics. Kinex has its headquarters in Buffalo and has grown to include laboratories and offices at other locations in the US and Worldwide. Prof. Hangauer is the inventor of two of Kinex’s cancer drugs that are currently in clinical trials in the US and abroad. He is an inventor or author on numerous patents and publications. He is also the recipient of numerous awards including the Canisius Department of Chemistry and Biochemistry James H. Crowdle Award for Distinction in Chemistry (2006), the New York State Research Foundation Outstanding Inventor Award (2002), the Niagara Frontier 2007 Inventor of the Year, and the 2012 University at Buffalo Faculty Entrepreneur of the Year.
Joseph Diliberto (CHM 1963): Research and Development Quality Assurance Manager (retired) at Bristol Myers Squibb.
Joseph Kuczkowski (CHM 1963, MS 1966): Goodyear Tire and Rubber Company (retired). Received his Ph.D. in Organic Chemistry from Wayne State University in 1968. Holds 23 U.S. patents in the rubber chemical and stabilization area. His most significant contribution to the Rubber Industry is his invention of Wingstay K. He is the recipient of the Rubber Division of the American Chemical Society's Melvin Mooney Award (2000) and Charles Goodyear Medal (2011).